Correlation Between Inhibrx and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Inhibrx and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Corvus Pharmaceuticals.
Diversification Opportunities for Inhibrx and Corvus Pharmaceuticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inhibrx and Corvus is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Inhibrx i.e., Inhibrx and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibrx and Corvus Pharmaceuticals
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.5 times less risky than Corvus Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 222.00 in Corvus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 687.00 from holding Corvus Pharmaceuticals or generate 309.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Inhibrx |
| Corvus Pharmaceuticals |
Inhibrx and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Corvus Pharmaceuticals
The main advantage of trading using opposite Inhibrx and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |